Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
about
The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trialsCorrelations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo.Clinical value of a patient-reported goal-attainment measure: the global development of self-assessment goal achievement (SAGA) questionnaire for patients with lower urinary tract symptoms.Relationships between symptoms, symptom bother, and health-related quality of life in patients with overactive bladder taking solifenacin or placebo in the VIBRANT study.Validation study of the Self-Assessment Goal Achievement (SAGA) questionnaire for lower urinary tract symptoms.Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
P2860
Q30894093-628A41C6-B42D-4DFC-BA1E-D5B0B57AD65AQ37114121-D2D15DE8-674B-4FD1-ADE7-7F97B2D2796BQ44037004-8336B869-5719-484F-9F49-A8234B4184BEQ46063282-3B349F41-1352-42AC-8F96-C120AED55BC8Q47904242-FF704546-FF03-441E-833D-A12F7E7C170AQ48389748-F94CDCCB-DEF2-44BC-B299-8BA0E350FEB0Q48673293-EA6D0EF7-8604-449F-B9F5-C6C8BF89058DQ48898796-469694F3-8A56-4780-BCD5-2BEB7744A4F2
P2860
Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Relationships between improvem ...... dder treated with tolterodine.
@en
Relationships between improvem ...... dder treated with tolterodine.
@nl
type
label
Relationships between improvem ...... dder treated with tolterodine.
@en
Relationships between improvem ...... dder treated with tolterodine.
@nl
prefLabel
Relationships between improvem ...... dder treated with tolterodine.
@en
Relationships between improvem ...... dder treated with tolterodine.
@nl
P2093
P1476
Relationships between improvem ...... dder treated with tolterodine.
@en
P2093
D A Gordon
D B Glasser
M Carlsson
Z Jumadilova
P304
P356
10.1111/J.1742-1241.2008.01778.X
P577
2008-06-01T00:00:00Z